Literature DB >> 8886886

Initial in vivo experience with EIT as a thermal estimator during hyperthermia.

K D Paulsen1, M J Moskowitz, T P Ryan, S E Mitchell, P J Hoopes.   

Abstract

Thermal imaging experiments using electrical impedance tomography (EIT) have been conducted during hyperthermia treatments delivered to two human patients and one animal subject. Coplanar and circumferential arrays of 16 and 32 tin-plated copper electrodes etched on a 0.005" polyimide sheet were used to inject 12.5 KHz current patterns of increasing sinusoidal spatial frequencies and subsequent potential distributions were recorded at each electrode site. Image reconstruction was achieved with a finite element method and difference images of conductivity changes during the course of treatment were formed. An assumed linear relationship (2%/degree C increase) between tissue impedance change and temperature change was used to produce thermal images of the treatment field in patients whereas an empirically measured nonlinear relationship obtained from excised tissue samples was applied retrospectively in the animal subject case. Reconstructed conductivity changes are shown to be possible given electrical data measured in vivo during hyperthermia delivery with conventional equipment (spiral microstrip applicator at 433 MHz). These correlated well with direct temperature measurements and demonstrated quantitative levels of agreement to the extent that estimated temperature accuracies were approximately 1.5 degrees C; although large errors (> 5 degrees C) did exist. This work suggests that EIT is a potentially useful tool for hyperthermia treatment monitoring and assessment. The relationship between tissue impedance and temperature is complex and confounds the ability to make simple correlations between conductivity and temperature changes. Further, study is required to discern whether this will ultimately limit EIT as a thermal estimator or whether it will lead to more fundamental uses of impedance as an indicator of thermal effect.

Entities:  

Mesh:

Year:  1996        PMID: 8886886     DOI: 10.3109/02656739609027666

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  6 in total

1.  Noninvasive thermometry assisted by a dual-function ultrasound transducer for mild hyperthermia.

Authors:  Chun-Yen Lai; Dustin E Kruse; Charles F Caskey; Douglas N Stephens; Patrick L Sutcliffe; Katherine W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-12       Impact factor: 2.725

Review 2.  Review of temperature dependence of thermal properties, dielectric properties, and perfusion of biological tissues at hyperthermic and ablation temperatures.

Authors:  Christian Rossmanna; Dieter Haemmerich
Journal:  Crit Rev Biomed Eng       Date:  2014

3.  Imaging with concave large-aperture therapeutic ultrasound arrays using conventional synthetic-aperture beamforming.

Authors:  Yayun Wan; Emad S Ebbini
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2008-08       Impact factor: 2.725

4.  Ultrasound phase contrast thermal imaging with reflex transmission imaging methods in tissue phantoms.

Authors:  Caleb H Farny; Gregory T Clement
Journal:  Ultrasound Med Biol       Date:  2009-08-14       Impact factor: 2.998

5.  On-Line Multi-Frequency Electrical Resistance Tomography (mfERT) Device for Crystalline Phase Imaging in High-Temperature Molten Oxide.

Authors:  Prima Asmara Sejati; Noritaka Saito; Yosephus Ardean Kurnianto Prayitno; Koji Tanaka; Panji Nursetia Darma; Miku Arisato; Kunihiko Nakashima; Masahiro Takei
Journal:  Sensors (Basel)       Date:  2022-01-28       Impact factor: 3.576

Review 6.  Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.

Authors:  Adela Ademaj; Danai P Veltsista; Pirus Ghadjar; Dietmar Marder; Eva Oberacker; Oliver J Ott; Peter Wust; Emsad Puric; Roger A Hälg; Susanne Rogers; Stephan Bodis; Rainer Fietkau; Hans Crezee; Oliver Riesterer
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.